FDC Financial Statement Analysis
|
||
The Revenues of FDC have increased by 16.74% YoY .
The Earnings Per Share (EPS) of FDC has decreased by -8.74 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
FDC Last 5 Annual Financial Results
[BOM: 531599|NSE : FDC]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr | ₹1,344 Cr | ₹1,091 Cr |
Expenses | ₹1,534 Cr | ₹1,274 Cr | ₹999 Cr | ₹1,051 Cr | ₹860 Cr |
Operating Profit (Excl OI) | ₹250 Cr | ₹254 Cr | ₹334 Cr | ₹293 Cr | ₹231 Cr |
Other Income | ₹51 Cr | ₹76 Cr | ₹97 Cr | ₹69 Cr | ₹43 Cr |
Interest | ₹4.09 Cr | ₹3.09 Cr | ₹3.43 Cr | ₹3.42 Cr | ₹1.44 Cr |
Depreciation | ₹39 Cr | ₹37 Cr | ₹38 Cr | ₹37 Cr | ₹33 Cr |
Profit Before Tax | ₹258 Cr | ₹289 Cr | ₹388 Cr | ₹320 Cr | ₹237 Cr |
Profit After Tax | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr | ₹170 Cr |
Consolidated Net Profit | ₹194 Cr | ₹216 Cr | ₹301 Cr | ₹240 Cr | ₹170 Cr |
Earnings Per Share (Rs) | ₹11.70 | ₹12.82 | ₹17.85 | ₹14.03 | ₹9.74 |
PAT Margin (%) | 10.54 | 13.74 | 22.06 | 17.40 | 15.15 |
ROE(%) | 9.84 | 11.71 | 18.36 | 16.03 | 12.48 |
ROCE(%) | 13.25 | 15.78 | 23.74 | 21.56 | 17.49 |
Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
Market Cap | : | ₹ 7,270.6 Cr |
Revenue (TTM) | : | ₹ 1,915.7 Cr |
Net Profit(TTM) | : | ₹ 289.4 Cr |
EPS (TTM) | : | ₹ 17.8 |
P/E (TTM) | : | 25.1 |
Industry Peers & Returns | 1W | 1M | 1Y |
FDC | 0% | 7.8% | 57.1% |
SUN PHARMACEUTICAL INDUSTRIES | 1.1% | -6.6% | 56.7% |
CIPLA | 0.2% | -4.4% | 54.3% |
DR REDDYS LABORATORIES | 4.3% | 2.6% | 29.9% |
ZYDUS LIFESCIENCES | 2.2% | -4.6% | 86.6% |
DIVIS LABORATORIES | 4.8% | 18.9% | 23.9% |
MANKIND PHARMA | -1.4% | 1.4% | NA |
TORRENT PHARMACEUTICALS | -1.7% | 3% | 65.8% |
LUPIN | 4.1% | 3% | 131.2% |
FDC Revenues
[BOM: 531599|NSE : FDC]
Y-o-Y | 16.74 % |
5 Yr CAGR | 13.09 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹1,784 Cr | 16.74 | |
Mar2022 | ₹1,528 Cr | 14.61 | |
Mar2021 | ₹1,333 Cr | -0.82 | |
Mar2020 | ₹1,344 Cr | 23.24 | |
Mar2019 | ₹1,091 Cr | - |
FDC Operating Profit
[BOM: 531599|NSE : FDC]
Y-o-Y | -1.61 % |
5 Yr CAGR | 1.95 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹250 Cr | -1.61 | |
Mar2022 | ₹254 Cr | -24.06 | |
Mar2021 | ₹334 Cr | 14.03 | |
Mar2020 | ₹293 Cr | 26.81 | |
Mar2019 | ₹231 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -15.72 % |
5 Yr CAGR | -9.85 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 13.99% | -15.72 | |
Mar2022 | 16.6% | -33.76 | |
Mar2021 | 25.06% | 15.01 | |
Mar2020 | 21.79% | 2.88 | |
Mar2019 | 21.18% | - |
FDC Profit After Tax
[BOM: 531599|NSE : FDC]
Y-o-Y | -10.34 % |
5 Yr CAGR | 3.39 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹194 Cr | -10.34 | |
Mar2022 | ₹216 Cr | -28.19 | |
Mar2021 | ₹301 Cr | 25.62 | |
Mar2020 | ₹240 Cr | 41.28 | |
Mar2019 | ₹170 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | -23.29 % |
5 Yr CAGR | -8.67 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 10.54 % | -23.29 | |
Mar2022 | 13.74 % | -37.72 | |
Mar2021 | 22.06 % | 26.78 | |
Mar2020 | 17.4 % | 14.85 | |
Mar2019 | 15.15 % | - |
FDC Earnings Per Share (EPS)
[BOM: 531599|NSE : FDC]
Y-o-Y | -8.74 % |
5 Yr CAGR | 4.69 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹12 | -8.74 | |
Mar2022 | ₹13 | -28.18 | |
Mar2021 | ₹18 | 27.23 | |
Mar2020 | ₹14 | 44.05 | |
Mar2019 | ₹9.74 | - |
FDC Return on Capital Employed (ROCE)
[BOM: 531599|NSE : FDC]
Y-o-Y | -16.03 % |
5 Yr CAGR | -6.71 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 13.25% | -16.03 | |
Mar2022 | 15.78% | -33.53 | |
Mar2021 | 23.74% | 10.11 | |
Mar2020 | 21.56% | 23.27 | |
Mar2019 | 17.49% | - |
FDC Share Price vs Sensex
Current Share Price | : | ₹446.6 |
Current MarketCap | : | ₹ 7,270.6 Cr |
Updated EOD on | : | May 02,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | 0% |
7.8% |
57.1% |
SENSEX | 1% |
2.2% |
23.7% |
FDC related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE 400 MIDSMALLCAP | 2.7% | 9% | 63% |
S&P BSE MIDSMALLCAP | 2.5% | 9.6% | 68.1% |
S&P BSE 500 | 1.7% | 4.8% | 39.5% |
S&P BSE ALLCAP | 1.7% | 5.3% | 41.6% |
S&P BSE HEALTHCARE | 1.6% | 2.5% | 56.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY MID SMALL400 | 2% | 8.6% | 64.9% |
NIFTY500 MULTICAP 50:25:25 | 1.7% | 6.4% | 49.4% |
NIFTY 500 | 1.7% | 5% | 40.6% |
NIFTY SMALLCAP250 | 1.5% | 11% | 71.2% |
You may also like the below Video Courses
FAQ about FDC Financials
How the annual revenues of FDC have changed ?
The Revenues of FDC have increased by 16.74% YoY .
How the Earnings per Share (EPS) of FDC have changed?
The Earnings Per Share (EPS) of FDC has decreased by -8.74 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs